Executive summary of the KDIGO 2022 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease: an update based on rapidly emerging new evidence-Reference-Cited by-同舟云学术

Executive summary of the KDIGO 2022 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease: an update based on rapidly emerging new evidence

Published:2022-11 Issue:5 Volume:102 Page:990-999
ISSN:0085-2538
Container-title:Kidney International
language:en
Short-container-title:Kidney International

Author:

Rossing Peter,Caramori M. Luiza,Chan Juliana C.N.,Heerspink Hiddo J.L.,Hurst Clint,Khunti Kamlesh,Liew Adrian,Michos Erin D.,Navaneethan Sankar D.,Olowu Wasiu A.,Sadusky Tami,Tandon Nikhil,Tuttle Katherine R.,Wanner Christoph,Wilkens Katy G.,Zoungas Sophia,Craig Jonathan C.,Tunnicliffe David J.,Tonelli Marcello A.,Cheung Michael,Earley Amy,de Boer Ian H.

Publisher

Elsevier BV

Subject

Nephrology

Reference44 articles.

1. Improving Global Outcomes Diabetes Work Group. KDIGO 2020 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease;Kidney Disease;Kidney Int,2020

2. GRADE guidelines: a new series of articles in the Journal of Clinical Epidemiology;Guyatt;J Clin Epidemiol,2011

3. Effects of structured versus usual care on renal endpoint in type 2 diabetes: the SURE study: a randomized multicenter translational study;Chan;Diabetes Care,2009

4. Effect of a web-based management guide on risk factors in patients with type 2 diabetes and diabetic kidney disease: a JADE randomized clinical trial;Chan;JAMA Netw Open,2022

5. Intensified multifactorial intervention in patients with type 2 diabetes mellitus and microalbuminuria: the Steno type 2 randomised study;Gaede;Lancet,1999

Cited by 125 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and safety of finerenone in individuals with type 2 diabetes mellitus complicated by diabetic kidney disease: A retrospective observational study;Metabolism Open;2024-12

2. Sequencing Quadruple Therapy for Heart Failure with Reduced Ejection Fraction: Does It Really Matter?;Heart Failure Clinics;2024-10

3. Diabetic kidney disease: The fourth pharmacological pillar may be semaglutide;Diabetes, Obesity and Metabolism;2024-09-02

4. Proteinuric and Non-Proteinuric Diabetic Kidney Disease: Different Presentations of the Same Disease?;Diabetology;2024-09-02

5. Finding Truth in Observational and Interventional Studies in Diabetes and Cardiovascular Disease;Journal of the American College of Cardiology;2024-09